content

Silgan Dispensing Introduces Gemini BE Nasal Pump at CPHI Frankfurt

To help pharmaceutical brands deliver faster-to-market nasal spray solutions, Silgan Dispensing, a global leader in the design, development and distribution of highly engineered pumps...

Biologics Offshore Likely To Grow In 2023, CPHI Study Claims

Part I of the CPHI Annual Report looks ahead at the potential for biologics outsourcing and contract manufacturing organisations (CMOs) in 2023 in advance...

In R&D, The UK Is Not Nearly As Far Ahead As Other Countries

According to a new report by IPPR, the UK's percentage of worldwide research and development (R&D) spending has decreased by 5% since 2014. Even...

Optimizing cold chain and fill-finish capabilities for the coming wave of mRNA technologies

Reacting rapidly after the initial onset of the pandemic the biopharma industry accelerated its research into advanced anti-viral modalities including messenger RNA (mRNA) vaccines....

FDA Under Pressure To Alter Accelerated Approval Program

The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by the protracted, complicated FDA process to discontinue commercialization of...

IFF to Highlight Industry-Leading Product Portfolio, Expertise at CPhI Frankfurt

IFF's Pharma Solutions division—backed by 300 years of combined cellulosic excipient experience and housing leading brands like Avicel® and METHOCEL™, plus a robust seaweed-based...

Andelyn Biosciences announces opening of its state-of-the-art GMP manufacturing facility to meet industry demand

Andelyn Biosciences, Inc., a world-leading gene therapy CDMO, announced the addition of a new GMP clinical and commercial manufacturing facility, the  Andelyn Corporate Center...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read